TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership353,979 shares
Latest Disclosed Value $ 11,759,182
Citigroup Inc ownership in 1TGTX / TG Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 353,979 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $9,791,059 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 483,525 shares of TG Therapeutics, Inc.. This represents a change in shares of -26.79% during the quarter. The current value of the position is $12,035,286 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 30,000 of underlying shares valued at $996,600 USD and put options representing 30,000 of underlying shares valued at $996,600 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 353,979 -129,546 -26.79 11,759 -18.41 0.0025
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 483,525 -263,394 -35.26 14,414 -46.58 0.0064
2025-11-10 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 746,919 60,897 8.88 26,982 9.29 0.0120
2025-08-11 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 686,022 336,918 96.51 24,690 79.36 0.0121
2025-05-12 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 349,104 1,927 0.56 13,765 31.72 0.0070
2025-02-12 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 347,177 178,900 106.31 10,450 165.57 0.0062
2024-11-12 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 168,277 93,730 125.73 3,936 196.76 0.0023
2024-08-12 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 74,547 -454,022 -85.90 1,326 -83.51 0.0008
2024-05-10 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 528,569 163,225 44.68 8,040 28.83 0.0053
2024-02-09 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 365,344 -67,993 -15.69 6,240 72.28 0.0044
2023-12-06 2023-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 433,337 233,650 117.01 3,623 -26.98 0.0027
2023-11-09 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 433,337 233,650 3,623 0.0011
2023-08-10 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 199,687 -253,615 -55.95 4,960 -27.24 0.0033
2023-05-11 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 453,302 22,351 5.19 6,818 33.72 0.0048
2023-02-09 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 430,951 -640,001 -59.76 5,098 -19.59 0.0041
2022-11-10 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 1,070,952 294,444 37.92 6,340 92.12 0.0045
2022-08-10 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 776,508 675,007 665.02 3,300 241.61 0.0025
2022-05-12 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 101,501 -410,320 -80.17 966 -90.07 0.0006
2022-02-10 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 511,821 430,157 526.74 9,725 257.93 0.0052
2021-11-10 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 81,664 -33,757 -29.25 2,717 -39.33 0.0016
2021-08-10 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 115,421 24,114 26.41 4,478 1.75 0.0027
2021-05-13 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 91,307 66,861 273.50 4,401 245.99 0.0028
2021-02-11 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 24,446 2,836 13.12 1,272 120.07 0.0008
2020-11-12 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 21,610 -74,192 -77.44 578 -69.04 0.0004
2020-08-12 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 95,802 -2,520 -2.56 1,867 93.07 0.0015
2020-05-12 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 98,322 -33,007 -25.13 967 -33.63 0.0009
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 131,329 -99,941 -43.21 1,457 12.16 0.0011
2019-11-08 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 231,270 -110,444 -32.32 1,299 -56.06 0.0010
2019-08-12 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 341,714 328,907 2,568.18 2,956 2,769.90 0.0024
2019-05-13 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 12,807 -495,166 -97.48 103 -95.06 0.0001
2019-02-12 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 507,973 336,978 197.07 2,083 117.43 0.0021
2018-11-13 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 170,995 71,537 71.93 958 -26.81 0.0009
2018-08-10 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 99,458 7,013 7.59 1,309 -0.23 0.0012
2018-05-11 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 92,445 -36,806 -28.48 1,312 23.77 0.0011
2018-02-12 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 129,251 33,036 34.34 1,060 -7.02 0.0008
2017-11-13 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 96,215 9,703 11.22 1,140 31.03 0.0009
2017-08-11 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 86,512 86,163 24,688.54 870 21,650.00 0.0008
2017-05-12 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 349 249 249.00 4 0.0000
2017-02-10 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 100 0 0.00 0 -100.00
2016-11-10 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 100 100 1 0.0000
2016-08-12 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -29,273 -100.00 0 -100.00
2016-05-13 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 29,273 25,590 694.81 249 465.91 0.0003
2016-02-12 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 3,683 -36,669 -90.87 44 -89.19 0.0000
2015-11-13 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 40,352 39,831 7,645.11 407 4,422.22 0.0004
2015-08-13 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 521 -1,751 -77.07 9 -75.00 0.0000
2015-05-14 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 2,272 -3,102 -57.72 36 -58.14 0.0000
2015-02-17 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 5,374 4,557 557.77 86 855.56 0.0001
2014-11-14 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 817 619 312.63 9 350.00 0.0000
2014-08-14 2014-06-30 13F TG THERAPEUTICS COM 88322Q108 198 -2,720 -93.21 2 -90.00 0.0000
2014-05-15 2014-03-31 13F TG THERAPEUTICS COM 88322Q108 2,918 -2,327 -44.37 20 0.00 0.0000
2014-02-14 2013-12-31 13F TG THERAPEUTICS COM 88322Q108 5,245 4,619 737.86 20 566.67 0.0000
2013-11-14 2013-09-30 13F TG THERAPEUTICS COM 88322Q108 626 -85 -11.95 3 -40.00 0.0000
2013-08-14 2013-06-30 13F TG THERAPEUTICS COM 88322Q108 711 711 5 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F TG THERAPEUTICS COM Call 30,000 997 n/a n/a n/a
2024-11-12 2024-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F TG THERAPEUTICS COM Call 74,900 87.72 1,332 119.80 n/a n/a n/a
2024-05-10 2024-03-31 13F TG THERAPEUTICS COM Call 39,900 -11.14 607 -20.89 n/a n/a n/a
2024-02-09 2023-12-31 13F TG THERAPEUTICS COM Call 44,900 -10.02 767 83.69 n/a n/a n/a
2023-12-06 2023-09-30 13F/A TG THERAPEUTICS COM Call 49,900 -6.55 417 -68.55 n/a n/a n/a
2023-11-09 2023-09-30 13F TG THERAPEUTICS COM Call 49,900 417 n/a n/a n/a
2023-08-10 2023-06-30 13F TG THERAPEUTICS COM Call 53,400 1,326 n/a n/a n/a
2023-05-11 2023-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F TG THERAPEUTICS COM Call 130,000 -80.50 1,538 -61.06 n/a n/a n/a
2022-11-10 2022-09-30 13F TG THERAPEUTICS COM Call 666,800 33.36 3,947 85.74 n/a n/a n/a
2022-08-10 2022-06-30 13F TG THERAPEUTICS COM Call 500,000 2,125 n/a n/a n/a
2022-05-12 2022-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F TG THERAPEUTICS COM Call 125,000 2,375 n/a n/a n/a
2021-05-13 2021-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F TG THERAPEUTICS COM Call 60,200 0.00 3,132 94.41 n/a n/a n/a
2020-11-12 2020-09-30 13F TG THERAPEUTICS COM Call 60,200 0.00 1,611 37.34 n/a n/a n/a
2020-08-12 2020-06-30 13F TG THERAPEUTICS COM Call 60,200 -16.27 1,173 65.91 n/a n/a n/a
2020-05-12 2020-03-31 13F TG THERAPEUTICS COM Call 71,900 -20.29 707 -29.37 n/a n/a n/a
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM Call 90,200 8.54 1,001 114.35 n/a n/a n/a
2019-11-08 2019-09-30 13F TG THERAPEUTICS COM Call 83,100 59.20 467 3.32 n/a n/a n/a
2019-08-12 2019-06-30 13F TG THERAPEUTICS COM Call 52,200 234.62 452 261.60 n/a n/a n/a
2019-05-13 2019-03-31 13F TG THERAPEUTICS COM Call 15,600 -49.35 125 -0.79 n/a n/a n/a
2019-02-12 2018-12-31 13F TG THERAPEUTICS COM Call 30,800 60.42 126 16.67 n/a n/a n/a
2018-11-13 2018-09-30 13F TG THERAPEUTICS COM Call 19,200 108 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F TG THERAPEUTICS COM Put 30,000 997 n/a n/a n/a
2024-11-12 2024-09-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F TG THERAPEUTICS COM Put 74,900 87.72 1,332 119.80 n/a n/a n/a
2024-05-10 2024-03-31 13F TG THERAPEUTICS COM Put 39,900 -11.14 607 -20.89 n/a n/a n/a
2024-02-09 2023-12-31 13F TG THERAPEUTICS COM Put 44,900 48.18 767 202.77 n/a n/a n/a
2023-12-06 2023-09-30 13F/A TG THERAPEUTICS COM Put 30,300 -30.82 253 -76.72 n/a n/a n/a
2023-11-09 2023-09-30 13F TG THERAPEUTICS COM Put 30,300 253 n/a n/a n/a
2023-08-10 2023-06-30 13F TG THERAPEUTICS COM Put 43,800 1,088 n/a n/a n/a
2023-05-11 2023-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F TG THERAPEUTICS COM Put 59,800 707 n/a n/a n/a
2022-05-12 2022-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F TG THERAPEUTICS COM Put 300,000 5,700 n/a n/a n/a
2021-05-13 2021-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F TG THERAPEUTICS COM Put 18,600 0.00 968 94.38 n/a n/a n/a
2020-11-12 2020-09-30 13F TG THERAPEUTICS COM Put 18,600 0.00 498 37.57 n/a n/a n/a
2020-08-12 2020-06-30 13F TG THERAPEUTICS COM Put 18,600 -4.12 362 89.53 n/a n/a n/a
2020-05-12 2020-03-31 13F TG THERAPEUTICS COM Put 19,400 1.04 191 -10.33 n/a n/a n/a
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM Put 19,200 -24.71 213 48.95 n/a n/a n/a
2019-11-08 2019-09-30 13F TG THERAPEUTICS COM Put 25,500 11.84 143 -27.41 n/a n/a n/a
2019-08-12 2019-06-30 13F TG THERAPEUTICS COM Put 22,800 98.26 197 114.13 n/a n/a n/a
2019-05-13 2019-03-31 13F TG THERAPEUTICS COM Put 11,500 8.49 92 113.95 n/a n/a n/a
2019-02-12 2018-12-31 13F TG THERAPEUTICS COM Put 10,600 -45.08 43 -60.19 n/a n/a n/a
2018-11-13 2018-09-30 13F TG THERAPEUTICS COM Put 19,300 108 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.